Home » Topics » BioWorld Science

BioWorld Science
RSS

MR-2088: a first-reported ULK1 inhibitor for RAS-driven cancers

March 24, 2022

GS-621763, oral prodrug with efficacy in models of SARS-CoV-2 infection

March 23, 2022

LifeMine and GSK establish strategic R&D collaboration

March 23, 2022

rVSV-deltaG-NiVBG vaccine protects monkeys from Nipah virus disease

March 23, 2022

AC Immune reports images of alpha-synuclein in human brain using new PET tracer

March 23, 2022

Moderna announces vaccine programs for respiratory disease and human coronaviruses

March 23, 2022

Spotlight Therapeutics to advance cell-targeted in vivo CRISPR gene editing biologics

March 23, 2022

Prellis and Sanofi collaborate on discovery of antibodies

March 23, 2022

Abbisko Therapeutics synthesizes new FGFR2/FGFR3 inhibitors

March 23, 2022

Cullgen discovers new PROTACs

March 23, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...